Protocol to identify fungal profile from fecal metagenomes in cancer patients prior to immunotherapy

被引：1

作者：

Huang, Xiaowen ^{[1
]}

Li, Lingxi ^{[1
]}

Chen, Haoyan ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Shanghai Canc Inst, Sch Med,Div Gastroenterol & Hepatol,Renji Hosp,Sta, Shanghai, Peoples R China

来源：

STAR PROTOCOLS | 2024年 / 5卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Bioinformatics; Cancer; Health Sciences; Microbiology;

D O I：

10.1016/j.xpro.2024.102847

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Identifying fungal profiles from metagenomes is challenging due to an incomplete fungal database and limitations in the understanding of software. Here, we describe a protocol for analyzing the fecal metagenome of cancer patients prior to immunotherapy. We describe steps for raw metagenomic sequencing data retrieval, human genome and contaminants elimination, and assigning taxonomy labels to fungal reads. We then detail measures for assessing fungal alpha diversity and beta diversity, along with differential analysis. For complete details on the use and execution of this protocol, please refer to Xiaowen Huang et al.1

引用

页数：13

共 50 条

[31] Clinical Efficacy of Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients Treated with Prior Radiotherapy
Glick, D.
Wall, E.
Lesperance, M.
Croteau, N.
Brooks, E.
Fenton, D.
Fiorino, L.
Geller, G.
Poonja, Z.
Ksienski, D.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S469 - S469
[32] EFFECTS OF PRIOR RADIATION ON OUTCOMES AMONG NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING IMMUNOTHERAPY
Hunting, John
Rowland, Courtney
Bloomer, Chance
Jabir, Abdur Rahman
Price, Sarah
Faucheux, Andrew
Olson, Eric
Norton, Dustin L.
Lycan, Thomas
CHEST, 2024, 166 (04) : 4153A - 4154A
[33] Emerging Risk Profile of Lung Cancer Immunotherapy: Unilateral Diffuse Alveolar Hemorrhage from Osimertinib
Forte, M.
Sangani, R. G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[34] Integrated genomic and methylation profile analysis to identify candidate tumor marker genes in patients with colorectal cancer
Huang, Guojun
Cheng, Wang
Xi, Fu
ONCOLOGY LETTERS, 2019, 18 (05) : 4503 - 4514
[35] Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
Di Gangi, Iole Maria
Mazza, Tommaso
Fontana, Andrea
Copetti, Massimiliano
Fusilli, Caterina
Ippolito, Antonio
Mattivi, Fulvio
Latiano, Anna
Andriulli, Angelo
Vrhovsek, Urska
Pazienza, Valerio
ONCOTARGET, 2016, 7 (05) : 5815 - 5829
[36] Identify Patients Likely to Benefit from Lung Cancer Screening Reply
Lazris, Andy
Roth, Alan R.
AMERICAN FAMILY PHYSICIAN, 2020, 101 (02) : 70 - 70
[37] The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patients
Zhang, Chuang
Mo, Hongmei
Li, Min
Wang, Shuaiyan
Dou, Xiaowen
Zhang, Xiuming
FRONTIERS IN ONCOLOGY, 2024, 14
[38] Profile and outcomes of patients with subsequent ovarian cancer diagnosis following a prior malignancy in the United States.
Akinyemi, Oluwasegun
Abodunrin, Faith
Andine, Tsion F.
Akinwumi, Bolarinwa
Akinyemi, Irene
Ojo, Ademola
Lipscombe, Christina
Silberstein, Peter T.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18541 - E18541
[39] Bioinformatic Approaches to Identify Novel Sphingosine Kinase-1 Inhibitors from Fungal Bioactives for Cancer Therapy
Ganaie, Majid Ahmad
Ali, Aarif
Shamoun, Maisa Ibrahim
Malla, Bashir Ahmad
Rehman, Muneeb U.
Ahmad, Sheikh Bilal
Rashid, Summya
Madkhali, Hassan Abdu
Albaqami, Faisal Fayih
Alharthy, Khalid Mofleh
Altharawi, Ali
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (10): : 5151 - 5164
[40] Practice protocol for the examination of specimens from patients with lung cancer
Nash, G
Hutter, RVP
Henson, DE
CANCER, 1996, 77 (10) : 2167 - 2174

← 1 2 3 4 5 →